Differentiating between various forms of hypertension presents challenges for physicians

November 2011
Endocrine Today;Nov2011, Vol. 9 Issue 11, p8
The article emphasizes the importance of differentiating and diagnosing the different forms of hypertension, along with the challenges it pose to physicians.


Related Articles

  • Common cardiovascular problems in the young: Part... Gutgesell, Howard P.; Atkins, Dianne L. // American Family Physician;11/15/1997, Vol. 56 Issue 8, p1993 

    Part II. Discusses the common cardiovascular problems in the young. Classification of hypertension by age group; Preparticipation screening of athletes; Recommendations for physical activity in school for children with heart disease.

  • Higher parathyroid hormone levels may raise hypertension risk. Byrne, Jen; Costa, Samantha; Swain, Erik; Taliercio, Adam; Volansky, Rob // Cardiology Today;Apr2014, Vol. 17 Issue 4, p54 

    The article reports that higher serum levels of parathyroid hormone could be linked to the pathogenesis of hypertension, which was concluded by the Multi-Ethnic Study of Atherosclerosis that evaluated patients enrolled from U.S. centers between 2000 and 2002.

  • Blood Pressure in Old Population. Gil-Extremera, Blas; Tuomilehto, Jaako; Cía-Gómez, Pedro // International Journal of Hypertension;2012, p1 

    An introduction is presented in which the editors discuss various papers within the issue on topics including the role of protein Klotho in cardiovascular disease, the benefits of antihypertensive treatment on hypertensive old patients, and the relationship between hypertension and dementia.

  • Variations in cardiovascular disease underdiagnosis in England: national cross-sectional spatial analysis. Soljak, Michael; Samarasundera, Edgar; Indulkar, Tejal; Walford, Hannah; Majeed, Azeem // BMC Cardiovascular Disorders;2011, Vol. 11 Issue 1, p12 

    Background: There is under-diagnosis of cardiovascular disease (CVD) in the English population, despite financial incentives to encourage general practices to register new cases. We compared the modelled (expected) and diagnosed (observed) prevalence of three cardiovascular conditions- coronary...

  • Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Pu, Qian; Larouche, Isabelle; Schiffrin, Ernesto L. // American Journal of Hypertension;Nov2003, Vol. 16 Issue 11, p931 

    Microvascular remodeling contributes to increased cardiovascular risk in hypertension. The dual angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) inhibitor omapatrilat improves small artery remodeling in hypertension. The aim of the present study was to compare effects of...

  • Is Low-Risk Hypertension Fact or Fiction?: Cardiovascular Risk Profile in the TROPHY Study Nesbitt, Shawna D.; Julius, Stevo; Leonard, David; Egan, Brent M.; Grozinski, Melissa // American Journal of Hypertension;Jul2005, Vol. 18 Issue 7, p980 

    Background: The Trial of Preventing Hypertension (TROPHY) Study is designed to establish whether treating high normal blood pressure with a low-dose angiotensin receptor blocker, candesartan cilexetil, for 2 years reduces the rate of progression to hypertension compared with placebo treatment...

  • HUMAN PARAOXONASE 1 (PON1) AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASE RISK ON A GROUP STUDY OF YOUNG HYPERTENSIVE PATIENTS. POPA, Călin; POPESCU, Cristina; PILAT, Luminiţa; PUŞCHIŢĂ, Maria // Studia Universitatis Vasile Goldis Seria Stiintele Vietii (Life ;Oct-Dec2013, Vol. 23 Issue 4, p477 

    Introduction: The incidence of cardiovascular diseases is increasing every year in our country and hypertension population is leaning to younger ages and for that we need an effective medical tool for prevention. Aim: Our objective is to analyse atherogenic risk data for young hypertensive...

  • A Lot of Primary Arterial Hypertensions. Only One Blood Pressure Therapeutic Target? CINTEZA, Mircea // Romanian Journal of Medical Practice;2014, Vol. 9 Issue 1, p3 

    The article discusses the possibility of targeting lower blood pressure (BP) values for patients with arterial hypertension (HT), which is contrary to prevailing guidelines of using higher BP therapeutic target of 140/90 millimeter hemoglobin (mm Hg). The author cites observations that the total...

  • Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review. Karbasi-Afshar, Reza; Saburi, Amin; Khedmat, Hossein // Journal of Tehran University Heart Center;2014, Vol. 9 Issue 1, p1 

    Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States and other industrialized countries, and the reported prevalence in the developing countries is also rather high. This disease is associated with a high rate of morbidity and mortality and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics